Could GLP-1 medications help slow cancer progression
Blood tests examining various hormones, thyroid function, and cardiac risk profile will give us valuable insights into your metabolic health and risk for conditions like high blood pressure, heart disease, and high cholesterol
Who should avoid Retatrutide
Additionally, fatigue emerged as a frequently discussed symptom, despite being less prominent in clinical trial data
Zepbound raked in $4.3 billion in the fourth quarter, which was up 123% year over year and an increase from $3.6 billion in the third quarter and, Yee noted, the drug continues to show robust growth despite compounded injectable GLP-1 Wegovy. Lilly is projecting 2026 sales to come in at between $80 billion and $83 billion, Fierce Pharma reported this week
Ultimately, taking small, consistent actions will lead to lasting change